Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Reactivation of hepatitis D virus after chemotherapy for diffuse large B cell lymphoma despite lamivudine prophylaxis.

Literature DB >> 20686876

Reactivation of hepatitis D virus after chemotherapy for diffuse large B cell lymphoma despite lamivudine prophylaxis.

Ellen Sloth Andersen¹, Jan Gerstoft, Nina Weis.

Abstract

We describe a case of reactivation of hepatitis D virus (HDV) in a patient treated with chemotherapy for a diffuse large B cell lymphoma despite lamivudine prophylaxis. This case suggests that previously cleared HDV should be considered when administering chemotherapy to patients with lymphoma.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 2010 PMID： 20686876 DOI： 10.1007/s12185-010-0648-z

Source DB: PubMed Journal: Int J Hematol ISSN： 0925-5710 Impact factor: 2.490

12 in total

1. Human CD4+ T-cell response to hepatitis delta virus: identification of multiple epitopes and characterization of T-helper cytokine profiles.

Authors: R Nisini; M Paroli; D Accapezzato; F Bonino; F Rosina; T Santantonio; F Sallusto; A Amoroso; M Houghton; V Barnaba
Journal: J Virol Date: 1997-03 Impact factor: 5.103

2. Treatment of chronic hepatitis delta with pegylated interferon-alpha2b.

Authors: Andreas Erhardt; Wolfram Gerlich; Christine Starke; Ulrike Wend; Andreas Donner; Abdurrahman Sagir; Tobias Heintges; Dieter Häussinger
Journal: Liver Int Date: 2006-09 Impact factor: 5.828

3. A randomized controlled trial of a 12-month course of recombinant human interferon-alpha in chronic delta (type D) hepatitis: a multicenter Italian study.

Authors: F Rosina; C Pintus; C Meschievitz; M Rizzetto
Journal: Hepatology Date: 1991-06 Impact factor: 17.425

Review 4. Hepatitis B virus (HBV) reactivation after cytotoxic or immunosuppressive therapy--pathogenesis and management.

Authors: L Xunrong; A W Yan; R Liang; G K Lau
Journal: Rev Med Virol Date: 2001 Sep-Oct Impact factor: 6.989

5. Smouldering hepatitis B virus replication in patients with chronic liver disease and hepatitis delta virus superinfection.

Authors: P Colombo; F Di Blasi; S Magrin; C Fabiano; V Di Marco; L D'Amelio; F Lojacono; G Spinelli; A Craxì
Journal: J Hepatol Date: 1991-01 Impact factor: 25.083

6. Role of hepatitis B, C, and D viruses in dual and triple infection: influence of viral genotypes and hepatitis B precore and basal core promoter mutations on viral replicative interference.

Authors: R Jardi; F Rodriguez; M Buti; X Costa; M Cotrina; R Galimany; R Esteban; J Guardia
Journal: Hepatology Date: 2001-08 Impact factor: 17.425

7. Does treatment of hepatitis B virus (HBV) infection reduce hepatitis delta virus (HDV) replication in HIV-HBV-HDV-coinfected patients?

Authors: Julie Sheldon; Belén Ramos; Carlos Toro; Pilar Ríos; José Martínez-Alarcón; Marcelle Bottecchia; Miriam Romero; Javier Garcia-Samaniego; Vincent Soriano
Journal: Antivir Ther Date: 2008

Review 1. Hepatitis B reactivation in the setting of chemotherapy and immunosuppression - prevention is better than cure.

Authors: Venessa Pattullo
Journal: World J Hepatol Date: 2015-05-08

Review 2. Prevention of Hepatitis B reactivation in the setting of immunosuppression.

Authors: Venessa Pattullo
Journal: Clin Mol Hepatol Date: 2016-06-13

2 in total